WASHINGTON, D.C. (AP) -- Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie....
By The Associated Press, Associated Press: Health
Fri, 12/19/2014 - 1:35pm
WASHINGTON, D.C. (AP) -- Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie....